Inspection Record

JD & SN Inc., dba Moses Lake Professional Pharmacy — FDA 483 Findings

US FDAInspected 2015-09-14Published 2024-01-17 12 findingsDeviation, CAPA, and investigationAseptic processing and sterility assuranceEquipment and facilityDocumentation and recordsLabeling and packagingStability and storageContamination control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Deviation, CAPA, and investigation

There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already dist ri buted.

2Aseptic processing and sterility assurance

Test procedures relative to appropriate laboratory testing for sterility and pyrogens are not written and followed.

3Equipment and facility

Routine calibration of equipment is not performed according to a written program designed to assure proper performance.S pecifically, the firm does not have any written procedure requiring the calibration of weights and thermometers.

4Documentation and records

Batch production and control records do not include complete infonnation relating to the production and control of each batch.

5Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established.

6Labeling and packaging

Procedures designed to assure that correct labeling are used for drug products are not written.

7Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.

8Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the to produce aseptic conditions.

9Stability and storage

Drug products do not bear an expiration date determined by appropriate stability data to assure they meet applicable standards of identity, strength, quality and purity at the time of use.

10Documentation and records

The master production and control records are deficient in that they do not include complete instructions.

11Contamination control

Protective apparel is not worn as necessary to protect drug products from contamination.

12Equipment and facility

Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriare design to facilitate op eration s for its intended use.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

JD & SN Inc., dba Moses Lake Professional Pharmacy company profile — full history US FDA documents, 2024 Go to Findings search